1. Home
  2. AUST vs LSB Comparison

AUST vs LSB Comparison

Compare AUST & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUST
  • LSB
  • Stock Information
  • Founded
  • AUST 2020
  • LSB 2002
  • Country
  • AUST Canada
  • LSB China
  • Employees
  • AUST N/A
  • LSB N/A
  • Industry
  • AUST
  • LSB
  • Sector
  • AUST
  • LSB
  • Exchange
  • AUST Nasdaq
  • LSB NYSE
  • Market Cap
  • AUST 21.2M
  • LSB 22.3M
  • IPO Year
  • AUST 2022
  • LSB N/A
  • Fundamental
  • Price
  • AUST $1.33
  • LSB $0.94
  • Analyst Decision
  • AUST
  • LSB
  • Analyst Count
  • AUST 0
  • LSB 0
  • Target Price
  • AUST N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • AUST 74.6K
  • LSB 21.6K
  • Earning Date
  • AUST 08-06-2025
  • LSB 07-07-2025
  • Dividend Yield
  • AUST N/A
  • LSB N/A
  • EPS Growth
  • AUST N/A
  • LSB N/A
  • EPS
  • AUST N/A
  • LSB N/A
  • Revenue
  • AUST N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • AUST N/A
  • LSB $39.33
  • Revenue Next Year
  • AUST N/A
  • LSB $75.61
  • P/E Ratio
  • AUST N/A
  • LSB N/A
  • Revenue Growth
  • AUST N/A
  • LSB N/A
  • 52 Week Low
  • AUST $0.80
  • LSB $0.36
  • 52 Week High
  • AUST $3.19
  • LSB $6.82
  • Technical
  • Relative Strength Index (RSI)
  • AUST 40.17
  • LSB 37.29
  • Support Level
  • AUST $1.38
  • LSB $0.91
  • Resistance Level
  • AUST $1.59
  • LSB $1.03
  • Average True Range (ATR)
  • AUST 0.10
  • LSB 0.06
  • MACD
  • AUST -0.04
  • LSB 0.01
  • Stochastic Oscillator
  • AUST 0.00
  • LSB 43.75

About AUST Austin Gold Corp.

Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: